Literature DB >> 18840075

Are hepatitis B e antigen (HBeAg)-positive chronic hepatitis B and HBeAg-negative chronic hepatitis B distinct diseases?

Mindie H Nguyen, Emmet B Keeffe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840075     DOI: 10.1086/592571

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis.

Authors:  Xue-Li Jin; Suk Kyun Hong; Hwajung Kim; Sun-Kyung Lee; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

Review 2.  Precore/core region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Seung Yeon Do; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

Review 3.  Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations.

Authors:  I-Chin Wu; Wen-Chun Liu; Ting-Tsung Chang
Journal:  J Biomed Sci       Date:  2018-06-02       Impact factor: 8.410

4.  HBV Transmission Risk Assessment in Healthcare Workers, Household and Sexual Contacts of HBV Infected Patients in the Southwest Region of Cameroon.

Authors:  Kukwah Anthony Tufon; Henry Dilonga Meriki; Tebit Emmanuel Kwenti; Nyeke James Tony; Ekeme Malika; Ayah Flora Bolimo; Youmbi Sylvain Kouanou; Theresa Nkuo-Akenji; Damian Nota Anong
Journal:  Oman Med J       Date:  2019-07

5.  G1896A Precore Mutation and Association With HBeAg Status, Genotype and Clinical Status in Patients With Chronic Hepatitis B.

Authors:  Jeyanthi Suppiah; Rozainanee Mohd Zain; Norazlah Bahari; Salbiah Haji Nawi; Zainah Saat
Journal:  Hepat Mon       Date:  2015-10-28       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.